Israel to Begin Human Trials on COVID-19 Vaccine

Israel will begin human trials for a potential COVID-19 vaccine on Nov. 1 after receiving regulatory approval, the Defense Ministry announced on Monday. The Israel Institute for Biological Research (IIBR) began animal trials for its “BriLife” vaccine in March. The Health Ministry and

Israel to begin human trials of coronavirus vaccine

The state-run Israel Institute for Biological Research announced Sunday that researchers will begin human testing on its coronavirus vaccine next week.The institute said clinical tests on an initial group of 80 people would begin Nov. 1. The testing is to expand to a second phase of 960 people in

UK Backs Human Challenge Studies of COVID-19 Vaccines With $44 Mln Fund

Britain said on Tuesday it would back human challenge studies to accelerate the development of COVID-19 vaccines by exposing volunteers to the virus after they had received a vaccine candidate. The government said it would invest 33.6 million pounds ($43.5 million) in the studies in partnership w

World Bank Approves $12 Bln for Coronavirus Vaccines

The World Bank said Tuesday that its executive board approved $12 billion for developing countries to finance the purchase and distribution of Covid-19 vaccines, tests and treatment. The financing "aims to support vaccination of up to a billion people," the bank said in a statement. The mo

Gulf Base for Russia’s Sputnik V Vaccine Production

Attempts are underway to launch a logistics base in the Gulf to produce Russia's COVID-19 vaccine, a Russian Direct Investment Fund (RDIF) senior official said. RDIF CEO Kirill Dmitriev said that more than 50 countries have already applied for Russia’s Sputnik V, indicating a number of requ

UAE to Host Second Human Trial Abroad of Russia's COVID-19 Vaccine

Human trials of Russia’s COVID-19 vaccine, named Sputnik V, will be held in the United Arab Emirates, the second country after Belarus to take part in the program of which results are expected before the end of November, Moscow said on Monday. The vaccine, first licensed by Russian authorit

UK study tests if BCG vaccine protects against COVID

The widely used BCG tuberculosis vaccine will be tested on frontline care workers in Britain for its effectiveness against COVID-19, researchers running the UK arm of a global trial said.Bacillus Calmette-Guérin (BCG) vaccine, used to protect against tuberculosis, induces a broad innate imm

Announcing the date of availability of the Corona vaccine in the United States

The US Secretary of Health, Alex Azar, said, Thursday, that sufficient doses of the Corona vaccine can be manufactured between March and April of next year, to be available to every American who wishes to have it. Reuters quoted Azar as saying at a hypothetical conference organized by Goldman Sac

China in Talks With WHO Over Assessing Its COVID-19 Vaccines for Global Use

China is in talks to have its locally-produced COVID-19 vaccines assessed by the World Health Organization (WHO), as a step toward making them available for international use, a WHO official said on Tuesday. Hundreds of thousands of essential workers and other groups considered at high risk in Ch

Germany approves third trial of COVID-19 vaccine candidate

Unlisted biotech firm IDT Biologika has won approval from Germany’s vaccine regulator to become the third German company after BioNTech and CureVac to launch human trials of an experimental coronavirus vaccine in the country. The trial of the vaccine, which has been developed with the Germa

Study: This vitamin reduces deaths and symptoms of corona "

A recent study, released in the United States, showed that patients with adequate levels of vitamin D are less likely to die from the Corona virus, or even to suffer from complications from the deadly virus, while another study found that this important vitamin also reduces infection rates. The s

Damage to exposure of medicines to heat and the importance of preservation

It is important to maintain the quality of the medicines we have, so we have to pay attention to the temperature of the place in which we put the medicines, as the high temperature may damage some medicines, and it is important to take a look at the accompanying leaflet inside each medicine box to

AstraZeneca resumes COVID-19 vaccine trials in South Africa, health dept says

AstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country’s Department of Health told Reuters on Tuesday.   Read: UK Working on 20-minute COVID-19 T

Trump signs new, expanded executive order to lower U.S. drug prices

President Donald Trump signed a new executive order on Sunday aimed at lowering drug prices in the United States by linking them to those of other nations and expanding the scope of a July action. “My Most Favored Nation order will ensure that our Country gets the same low price Big Pharma

Taiwan says plans to sign up for 'COVAX' vaccine allocation scheme

Taiwan will sign up to the "COVAX" global vaccine allocation plan to ensure it will be able to access a COVID-19 vaccine when one becomes available, the island's health minister said on Saturday. Chen Shih-chung told reporters in Taipei that the government had engaged lawyers to enter discussions

China's Sinovac coronavirus vaccine candidate appears safe, slightly weaker in elderly

Chinese firm Sinovac Biotech Ltd (SVA.O) said on Monday its coronavirus vaccine candidate appeared to be safe for older people, according to preliminary results from an early to mid-stage trial, while the immune responses triggered by the vaccine were slightly weaker than younger adults. Health o

UK Working on 20-minute COVID-19 Test

The British government said it is investing in a coronavirus test that gives results in as little as 20 minutes. This came as critics complain that tests for the virus are being rationed because the system can’t cope with demand. Health Secretary Matt Hancock said the government is expandi

Third UK COVID-19 vaccine reaches human trial stage

LONDON: A team of scientists at Cambridge University is set to begin human trials for a new vaccine for COVID-19 that could potentially work against other coronavirus diseases. It is the third UK-based project to reach this stage of development, following vaccines currently being developed by tea

Person of the Year